Vantage News

In close collaboration with the UN Office for Coordination of Humanitarian Affairs (OCHA), we are excited to announce the launch of a new Business Case Study, which looks at why and how the private sector engages in humanitarian action, unpacking the "business case" for collaboration between companies and humanitarian organizations.
Read More »
Alliance Callout


By working with Vantage, companies can maximize the performance of individual alliances, put under-performing alliances back on track, and ensure coordination and optimization of their entire alliance portfolio.
Read More »
SSM Call Out

Sourcing & Supply Chain Management

We specialize in procurement and supply chain transformation, category strategy development, SRM program implementation, negotiation advice, and training for procurement leaders and professionals.
Read More »
Sales Advisory

Sales and Account Management

We help sales organizations develop and implement innovative methods for negotiating and collaborating with customers.
Read More »
Slide 1

Enterprise Learning

We work with organizations to create and deliver highly interactive, experiential learning strategies that translate into real, measurable business results and are aimed at developing employees’ abilities in the most fundamental and critical areas of business relationship management.
Read More »

Vantage in HBR


Vantage in Harvard Business Review

HBR Guide to NegotiatingHBR Guide to Negotiating now in Paperback by Jeff Weiss.

HBR Video:  Jeff Weiss Offers Tips and Advice on Negotiating


Sales study imageVantage's Pricing Study highlighted in HBR's January 2015 Issue


Recent Publications

  • Better Skills, Better Partnering


    Although the pharmaceutical industry has been quick to embrace the value of partnerships and the subsequent improved access to new business opportunities, initially many companies did not fully understand what it really takes to be successful at alliance partnering. In the past five years, as partnering has become the new normal, Bayer and many other biopharma companies have sought to remedy this by building their corporate partnering capability. As this continues, all pharmaceutical companies will benefit from operating in an industry that is increasingly capable at partnering.

  • Biotalk Podcast with Stuart Kilman and Josh Hamermesh


    Stuart Kliman recently appeared with Josh Hamermesh, Vice President at Locust Walk, on an episode of Biotalk, a Locust Walk Podcast series. They discussed ways of optimizing alliance management, maximizing long-term deal value creation for life science companies, and the differences between deal-minded and implementation-minded negotiation approaches.

  • Alliance Management Required: The Unique Alliance Management Needs of Pharma Option Deals


    As pharmaceutical and mid-sized biotech companies increasingly seek to enhance their pipelines through externalized relationships, the option deal—typically with a smaller biotech—has become an increasingly popular contract structure.

View All Articles »